MIR3689F

Across TCGA pan-cancer cohorts, MIR3689F RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR3689F data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR3689F RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3689F expression acts as an unfavorable survival marker.

THCA, MESO, and BLCA are the cancer types where MIR3689F RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.032	0.950	<.001	144	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	126	view →
BLCA	OS	Tertile	All	0.230	0.723	<.001	81	view →
READ	DFS	Tertile	All	0.420	0.816	<.001	81	view →
KIRC	OS	Tertile	All	0.642	0.883	.001	72	view →
OV	OS	Tertile	All	0.293	0.691	.002	54	view →
STAD	OS	Tertile	III,IV	0.113	0.642	<.001	54	view →
ESCA	DFS	Tertile	II,III,IV	0.201	0.531	.007	54	view →
COAD	DFS	Tertile	All	0.170	0.790	.002	45	view →
THYM	OS	Tertile	All	0.186	0.931	<.001	45	view →
UCEC	DFS	Tertile	All	0.084	0.649	<.001	36	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR3689F–THCA (OS)

Open the THCA breakdown →